ライフサイエンスコーパス: sex hormone-binding globulin

1 one sulfate, androstanediol glucuronide, and sex hormone binding globulin).

2 Both drugs bind to sex hormone binding globulin.

3 vel of steroid sex hormone or a low level of sex hormone binding globulin.

4 s were assayed for estrogens, androgens, and sex hormone-binding globulin.

5 d by hormonal contraceptives and mediated by sex hormone-binding globulin.

6 rostane-3alpha, 17beta-diol-glucuronide, and sex hormone-binding globulin.

7 ved at the plasma membrane by a receptor for sex hormone-binding globulin.

8 ficant for several estrogens, androgens, and sex hormone-binding globulin (2-sided P <or= 0.01).

9 follicle-stimulating hormone, estradiol, and sex hormone-binding globulin-adjusted estradiol (free es

10 l: 0.01, 0.03) and inverse associations with sex hormone-binding globulin and follicle-stimulating ho

11 The G domains are related to those found in sex hormone-binding globulin and to those utilized by la

12 ing serum levels of testosterone, estradiol, sex hormone binding globulin, and androstenediol glucuro

13 roportion of variability (6% after fat mass, sex hormone binding globulin, and insulin levels were ad

14 There were no differences in testosterone, sex hormone-binding globulin, and blood lipids between t

15 ucose, insulin, C-peptide, 17beta-estradiol, sex hormone-binding globulin, and IL-4.

16 negatively associated with concentrations of sex-hormone binding globulin, and positively associated

17 Low circulating levels of sex hormone-binding globulin are a strong predictor of t

18 gnificant differences in total estradiol and sex hormone binding globulin at the completion of the in

19 minase (beta = 0.002; P = 3 x 10(-5)), lower sex-hormone-binding globulin (beta = -0.010; P = 9 x 10(

20 mproved and levels of C-reactive protein and sex hormone-binding globulin but not interleukin-6 incre

21 2 pmol per liter) (P = 0.009), and the serum sex hormone-binding globulin concentration increased fro

22 (decreased blood concentration and increased sex hormone-binding globulin concentration).

23 in resistance (P=6 x 10(-4)) and lower serum sex hormone binding globulin concentrations (P=5 x 10(-4

24 ble serum estradiol concentrations and serum sex hormone-binding globulin concentrations of 1 microg

25 y study that provides multivariably adjusted sex hormone-binding globulin data indicates that this bi

26 ween the fifth LNS (laminin-alpha, neurexin, sex hormone-binding globulin) domain and the third EGF-l

27 the single LNS-domain (for laminin/neurexin/sex hormone-binding globulin-domain) of neurexin-1beta o

28 ostenedione, dehydroepiandrosterone sulfate, sex hormone-binding globulin, estrone, estradiol, C-pept

29 izing hormone, follicle-stimulating hormone, sex hormone-binding globulin, F(2)-isoprostanes, and thi

30 Serum testosterone, estradiol, sex hormone binding globulin, gonadotropins, and bone de

31 centrations and high serum concentrations of sex hormone-binding globulin have an increased risk of h

32 ke with endogenous androgens, estrogens, and sex hormone-binding globulin in 728 white postmenopausal

33 Serum sex hormone binding globulin increased and leptin decrea

34 riol, testosterone, progesterone, prolactin, sex hormone binding globulin, insulin-like growth factor

35 Total-body BMD, sex hormone binding globulin, leptin, and estrone were m

36 Demented women had higher mean serum sex hormone binding globulin levels than nondemented wom

37 ide polymorphism (SNP) rs6259 had 10% higher sex hormone-binding globulin levels (P=0.005), and carri

38 Circulating sex hormone-binding globulin levels are inversely associ

39 A dramatic 45-fold increase in sex hormone-binding globulin levels during hibernation d

40 free testosterone (FT) levels decreased and sex hormone-binding globulin levels increased in tandem

41 Estradiol, estrone, and sex hormone-binding globulin levels increased in the est

42 Testosterone, estradiol, and sex hormone-binding globulin levels were measured in ser

43 Sex hormone-binding globulin levels were positively asso

44 directions corresponding to their associated sex hormone-binding globulin levels.

45 analogs, we demonstrated that the C terminus sex hormone-binding globulin-like (SHBG) domain of PS is

46 main that we term Pentraxin/Laminin/neurexin/sex-hormone-binding-globulin-Like (PLL).

47 ins are largely composed of laminin-neurexin-sex hormone-binding globulin (LNS)/laminin G domains, wh

48 by gamma-glutamyltransferase, fetuin-A, and sex hormone-binding globulin), markers of dyslipidemia (

49 .58) among men, a finding that suggests that sex hormone-binding globulin may have a causal role in t

50 strone, progesterone, free testosterone, and sex hormone binding globulin measurements.

51 ; positive associations for progesterone and sex hormone binding globulin merit additional study.

52 CI: 1.12, 1.68; P = 0.002) and a decrease in sex hormone-binding globulin (OR = 0.60, 95% CI: 0.45, 0

53 peptide (NT-proBNP), total testosterone, and sex hormone-binding globulin plasma levels in 4,056 men

54 e (r = 0.37)) and negatively correlated with sex hormone-binding globulin (r = -0.48).

55 ree androgen index (FAI) (total testosterone/sex hormone-binding globulin ratio).

56 ation of known and unknown recombinant human sex hormone-binding globulin (rhSHBG)-binding designer s

57 sport proteins human serum albumin (HSA) and sex hormone binding globulin (SHBG) as models.

58 ia receptors for the steroid-binding protein sex hormone binding globulin (SHBG) by attempting to blo

59 Testosterone, estradiol, and sex hormone binding globulin (SHBG) concentrations were

60 In the sex hormone binding globulin (SHBG) gene, a pentanucleot

61 Sex hormone binding globulin (SHBG) is found in the brai

62 We measured testosterone, estradiol, and sex hormone binding globulin (SHBG) levels and calculate

63 l studies consistently show that circulating sex hormone binding globulin (SHBG) levels are lower in

64 teins, but there is evidence that binding to sex hormone binding globulin (SHBG) might enhance tumor

65 these agents for PET imaging is needed since sex hormone binding globulin (SHBG), a glycoprotein whic

66 ne, dehydroepiandrosterone sulfate (DHEAS)], sex hormone binding globulin (SHBG), and EOC risk by tum

67 e (FT), bioavailable testosterone (BAT), and sex hormone binding globulin (SHBG).

68 ncentrations of all other lipid moieties and sex hormone binding globulin (SHBG).

69 en was associated with serum sex steroids or sex hormone binding globulin (SHBG).

70 owever, after including % estradiol bound to sex hormone-binding globulin (SHBG) and total estradiol

71 away from estrogens and toward androgens and sex hormone-binding globulin (SHBG) as potential mediato

72 It is known that unliganded sex hormone-binding globulin (SHBG) binds to a receptor

73 one, free testosterone, androstenedione, and sex hormone-binding globulin (SHBG) concentrations (seco

74 lored associations of total testosterone and sex hormone-binding globulin (SHBG) concentrations at ag

75 , androstanediol glucuronide, estradiol, and sex hormone-binding globulin (SHBG) for 3,043 cases and

76 hydroepiandrosterone sulfate, prolactin, and sex hormone-binding globulin (SHBG) improved risk predic

77 concentrations of estrogens, androgens, and sex hormone-binding globulin (SHBG) in a population-base

78 Sex hormone-binding globulin (SHBG) is a plasma protein

79 Sex hormone-binding globulin (SHBG) is an important regu

80 Sex hormone-binding globulin (SHBG) is believed to play

81 Sex hormone-binding globulin (SHBG) is the high-affinity

82 Low plasma sex hormone-binding globulin (SHBG) levels are associate

83 ine increased and significantly decreased as sex hormone-binding globulin (SHBG) levels at follow-up

84 (LH), follicle-stimulating hormone (FSH) and sex hormone-binding globulin (SHBG) levels were measured

85 reast cancer risk by stimulating circulating sex hormone-binding globulin (SHBG) levels.

86 ne whether plasma levels of sex hormones and sex hormone-binding globulin (SHBG) may account for the

87 concentrations of estrogens, androgens, and sex hormone-binding globulin (SHBG) was investigated in

88 udy were analyzed to examine whether ESH and sex hormone-binding globulin (SHBG) were associated with

89 serum concentrations of total testosterone, sex hormone-binding globulin (SHBG), dehydroepiandroster

90 a are available regarding the association of sex hormone-binding globulin (SHBG), testosterone, and t

91 with participants in the lowest quartile of sex hormone-binding globulin (SHBG), those in the highes

92 ating hormone (FSH), total testosterone, and sex hormone-binding globulin (SHBG), were performed in 6

93 t-specific 6 chimeras, with either the whole sex hormone-binding globulin (SHBG)-like domain (Val243-

94 nent to circulating sex steroid hormones and sex hormone-binding globulin (SHBG).

95 inverse relations between serum insulin and sex hormone-binding globulin (SHBG).

96 rations of high-density lipoprotein (9%) and sex-hormone binding globulin (SHBG) (21%), and lower con

97 Mean plasma concentrations of total and sex-hormone-binding-globulin (SHBG)-bound testosterone w

98 ured; two polymorphisms of the gene encoding sex hormone-binding globulin, SHBG, that were robustly a

99 ata demonstrate that higher androgens, lower sex hormone-binding globulin, surgical menopause, and ea

100 Serum concentrations of sex hormone-binding globulin that were 1.0 microg per de

101 -estradiol, the ratio of 17beta-estradiol to sex hormone-binding globulin, the fasting insulin resist

102 unassociated with cognitive composites, but sex hormone binding globulin was positively associated w

103 rd-deviation increase in the plasma level of sex hormone-binding globulin was 0.28 (95% CI, 0.13 to 0

104 eptin, and C-reactive protein were lower and sex hormone-binding globulin was higher in the low-prote

105 e sulfate, follicle-stimulating hormone, and sex hormone-binding globulin were measured.

106 Plasma levels of sex hormone-binding globulin were measured; two polymorp

107 Among women, higher plasma levels of sex hormone-binding globulin were prospectively associat

108 Other antiepileptic drugs increase sex hormone-binding globulin, which reduces the bioactiv

109 es in the Laminin A G domain, Neurexins, and Sex hormone-binding globulin, with three interspersed ep